Pancreatic Insufficiency Clinical Trial
Official title:
One Week Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Center Study With Creon® 25000 Minimicrospheres™ in Subjects With Pancreatic Exocrine Insufficiency After Pancreatic Surgery, Followed by an Open-Label Long-Term Extension of 1 Year
This study will provide efficacy data for Creon 25000 MMS in PS patients as well as long-term safety data. During the long-term treatment with Creon 25000 nutritional parameters will be assessed and correlated with CFA
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03279653 -
Pancreatic Exocrine Insufficiency After Bariatric Surgery
|
N/A | |
| Completed |
NCT00763412 -
Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis
|
N/A | |
| Recruiting |
NCT01851694 -
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
|
N/A | |
| Completed |
NCT01710644 -
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
|
Phase 1/Phase 2 | |
| Completed |
NCT01988350 -
Pancreatic Insufficiency Secondary to Tobacco Exposure
|
N/A | |
| Active, not recruiting |
NCT01012908 -
Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency
|
Phase 2/Phase 3 | |
| Completed |
NCT01879228 -
Effect of Chronic Incretin-based Therapy in Cystic Fibrosis
|
N/A | |
| Completed |
NCT00705978 -
Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis
|
Phase 3 | |
| Completed |
NCT00095732 -
Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency
|
Phase 2 | |
| Completed |
NCT00513682 -
Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)
|
Phase 3 | |
| Recruiting |
NCT05466838 -
PERT to Improve Quality of Life in Patients Undergoing Pancreaticoduodenectomy: A Pilot Randomized Controlled Trial
|
N/A | |
| Completed |
NCT02979340 -
MRI to Characterize and Predict CF Liver Disease in PUSH Cohort
|
||
| Completed |
NCT00432861 -
Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis
|
Phase 3 | |
| Completed |
NCT00406536 -
Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI
|
Phase 2 | |
| Completed |
NCT01144507 -
Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis
|
||
| Completed |
NCT05700604 -
Hypoglycemia and Glucagon Response in CF
|
||
| Terminated |
NCT02985801 -
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03551691 -
Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)
|
Phase 2 | |
| Recruiting |
NCT03450772 -
Equivalence Study to Compare Two Strengths of Creon in China
|
Phase 3 | |
| Completed |
NCT00572975 -
Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea
|
Phase 4 |